AT–HOME HEALTH TEST

Celiac Disease Monitoring

  • Enhanced Biomarker monitoring

  • Scientifically validated testing

  • Results you can track over time

Monitoring Plan

Every 4 Months

One-time purchase

The first two kits are shipped immediately and 75 days later. All future kits are shipped at Every 4 Months intervals, until your cancellation.

Celiac Disease Monitoring Suite
  • Enhanced Biomarker monitoring

  • Scientifically validated testing

  • Results you can track over time

Monitoring Plan

Every 4 Months

One-time purchase

The first two kits are shipped immediately and 75 days later. All future kits are shipped at Every 4 Months intervals, until your cancellation.

imaware™ is helping patients manage and track the effectiveness of their gluten-free diet.

Celiac Disease patients do not follow-up as often as they should

1.5M

Americans are currently diagnosed with Celiac Disease

73%

Do not follow up with a Doctor

Want to know if your gluten-free diet is effective?

Making major lifestyle and dietary changes after diagnosis is difficult, especially for those recently diagnosed. A majority of people do not follow-up with their doctors after invoking the gluten-free diet, and healing may not fully take place.

Studies have shown that it can take between 15-20 months of strict gluten-free diet before complete internal healing can take place. It is critical to be monitored during this phase to ensure your diet and lifestyle are providing you the needed benefits.

imaware™ helps you monitor and track the effectiveness of your gluten-free diet.

Don’t leave the celiac awareness question unanswered

Choose a quick and easy testing experience

It takes the average American at least 15 months of strict gluten-free diet and lifestyle to begin fully healing. imaware™ provides ongoing monitoring and results within 5 days to help you stay on track.

Take advantage of earlier guidance and feedback

Earlier feedback and validation of your diet and lifestyle changes are critical for long term healing and quality of life.

imaware Product Presentation

Designed alongside world-class doctors

imaware™ designs and validates each at-home health test alongside world-renowned medical doctors and scientific researchers.

Dr. GuandaliniMedical Director of the University of Chicago Celiac Disease Center.

Dr. SchuppanDiscovered the tTG biomarker for use in the identification of Celiac Disease.

Designed & Validated by Doctors

imaware™ uses the same tests that are currently requested by healthcare professionals for monitoring. Such monitoring is considered important in checking the post diagnosis adherence to the diet as well as its effectiveness"
Dr. Stefano GuandaliniMedical Director, University of Chicago Celiac Disease Center

Designed & Validated by Doctors

imaware™ uses the same tests that are currently requested by healthcare professionals for monitoring. Such monitoring is considered important in checking the post diagnosis adherence to the diet as well as its effectiveness"
Dr. Stefano GuandaliniMedical Director, University of Chicago Celiac Disease Center

imaware™ At-Home Celiac Disease Monitoring

At-home Collection

imaware™ tests are completed in the comfort of your own home with just a small finger prick. No prescription required.

Easy

Complete in under 5 minutes

imaware™ tests use a simple painless process that can be completed in under 5 minutes from the comfort of your own home.

A more accurate analysis

Patented imaware™ technologies create reports for patients that provide high levels of accuracy, reducing the number of unnecessary patient visits to their doctor.[C][D][E][F]

Precise

Enhanced biomarker monitoring

The preferred monitoring tests utilize multiple biomarkers including tTG-IgA. imaware™ tests for tTG-IgA along with 3 additional biomarkers to provide a more comprehensive result.[G][H][I][J][K]

Designed with Dietitians

Our reports have been reviewed by many leading Registered Dietitians so you can feel confident your results will help you heal faster.

Empowering

Easy to understand online report

Access your results anywhere, any time, and share them easily with your healthcare professional.

Monitoring using tTG and DGP Biomarkers

We utilize the highly sensitive and specific Tissue Transglutaminase (tTG) Antibody, or tTG-IgA biomarker for monitoring the majority of diagnosed celiac disease patients.

This biomarker has been studied to show reduction of 50% every 50 days when a strict gluten-free diet is maintained. In some patients, we review the tTG and DGP IgG biomarkers to collect and present this information.

Utilizing this approach aligns with the same process currently used by the medical community to provide check-up on patients after diagnosis. Ensuring your values decrease over time is critical to promoting healing.

Using an imaware™ collection kit

The imaware™ home collection kit is easy to use, painless, and requires only 5 drops of blood.

1

Draw 5 drops of blood

Use the pain-free lancet by pressing it against the tip of your finger and press the button

2

Collect in the microtube

Collect the drops of blood from your finger into a microtube

3

Secure and return microtube

Secure the microtube, and mailing it back to us with the provided return label.

4

Check your results online

Your results are available online for review within 5 days

Partners for Celiac Disease Awareness

We're working with our partners to increase awareness of celiac disease home-based monitoring plus education and community building.

Take the test. Change your life.

Ready to join the thousands of Americans taking control of their health?

Monitoring Plan

Every 4 Months

One-time purchase

The first two kits are shipped immediately and 75 days later. All future kits are shipped at Every 4 Months intervals, until your cancellation.

Celiac Disease Monitoring Suite

Monitoring Plan

Every 4 Months

One-time purchase

The first two kits are shipped immediately and 75 days later. All future kits are shipped at Every 4 Months intervals, until your cancellation.

Still have questions about how imaware™ works?

Here are just a few of the things people frequently ask about imaware. If you don’t see your question here, get in touch with us by clicking here.

How do I prepare for my celiac disease monitoring?
There is nothing special you must do to prepare for your celiac disease monitoring. This test will instead provide awareness to your gluten consumption to support monitoring.
What are celiac disease biomarkers?
A celiac-specific biomarker is a measurable indicator of your body's response or condition to gluten. The two most common celiac biomarkers are tTG and DGP. In patients with celiac disease, these specific biomarkers are found to be elevated.
What makes the imaware™ celiac disease monitoring test unique?
imaware™ is a comprehensive monitoring test for celiac disease that utilizes the same tests that are currently requested by medical professional for monitoring.
Is the imaware™ celiac disease monitoring as accurate as a DNA test for celiac disease?
imaware™ celiac disease monitoring is more accurate, as it tests your blood for presence of celiac disease biomarkers. DNA kits test for the genetic markers that may indicate a predisposition for celiac disease.
What is the difference between celiac disease and non-celiac gluten sensitivity?
Celiac disease is an auto-immune disorder that occurs in response to the ingestion of gluten. Non-celiac gluten sensitivity is the least understood reaction to gluten, and can be investigated after celiac disease is ruled out.
Are there any special return shipping instructions?
No, simply drop-off the package in the provided shipping bag at any USPS mailbox or store location at any time.
View the notes of scientific references for claims made on this page
A
Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al.
The prevalence of celiac disease in the United States.
Am J Gastroenterol 2012; 107(10):1538-44
B
Wessels MMS, de Rooij N, Roovers L, Verhage J, de Vries W, Mearin ML.
Towards an individual screening strategy for first-degree relatives of celiac patients. Eur J Pediatr. 2018.
C
Akobeng AK.
Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice.
Acta Pædiatrica 2006; 96:487–91
D
Sonis J.
How to Use and Interpret Interval Likelihood Ratios.
Fam Med 1999; 31(5):432-7
E
Parikh R, Parikh S, Arun E, et al.
Likelihood ratios: Clinical application in day-to-day practice.
Indian J Ophthalmol. 2009; 57(3): 217–221
F
Vermeersch P, Richter T, Hauer AC, et al.
Use of likelihood ratios improves clinical interpretation of IgG and IgA anti-DGP antibody testing for celiac disease in adults and children.
Clinical Biochemistry 2011; 44:248–250
G
Giersiepen K(1), Lelgemann M, Stuhldreher N, Ronfani L, Husby S, Koletzko S,Korponay-Szabó IR; ESPGHAN Working Group on Coeliac Disease Diagnosis.
Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.
J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):229-41. doi: 10.1097/MPG.0b013e318216f2e5.
H
Matthijs Oyaert, Pieter Vermeersch, Gert De Hertogh, Martin Hiele, Nathalie Vandeputte, Ilse Hoffman and Xavier Bossuyt*
Combining antibody tests and taking into account antibody levels improves serologic diagnosis of celiac disease
DOI 10.1515/cclm-2013-1099 Received December 21, 2013; accepted January 9, 2015; previously published online February 19, 2015
I
Ingrid Dahlboma, Britt-Inger Nyberga, Lillemor Berntsona and Tony Hansson
Simultaneous detection of IgA and IgG antibodies against tissue transglutaminase: The preferred pre-biopsy test in childhood celiac disease Departments of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden; Departments of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 26 February 2016
J
Pieter Vermeersch,* Karel Geboes,‡ Godelieve Mariën,* Ilse Hoffman,§ Martin Hiele,︎ and Xavier Bossuyt
Defining Thresholds of Antibody Levels Improves Diagnosis of Celiac Disease
K
Lakos G, Norman GL, Mahler M, et al.
Analytical and Clinical Comparison of Two Fully Automated Immunoassay Systems for the Diagnosis of Celiac Disease.
Journal of Immunology Research, vol. 2014, Article ID 371263, 9 pages, 2014. https://doi.org/10.1155/2014/371263

Discover our tests

Heart Disease Test

Learn More

Prostate Cancer Test

Learn More